These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 34739174
1. Usefulness of brain natriuretic peptide to distinguish Kawasaki disease from cervical lymphadenitis. Muto T, Masuda Y, Nakamura N, Numoto S, Kodama S, Miyamoto R, Miyata K, Hayakawa T, Mori H, Kuroyanagi Y, Akaihata M, Iwayama H, Kurahashi H, Shimomura Y, Nagai T, Hori T, Agata H, Okumura A. Pediatr Int; 2022 Jan; 64(1):e15050. PubMed ID: 34739174 [Abstract] [Full Text] [Related]
2. Lymph-node-first presentation of Kawasaki disease compared with bacterial cervical adenitis and typical Kawasaki disease. Kanegaye JT, Van Cott E, Tremoulet AH, Salgado A, Shimizu C, Kruk P, Hauschildt J, Sun X, Jain S, Burns JC. J Pediatr; 2013 Jun; 162(6):1259-63, 1263.e1-2. PubMed ID: 23305955 [Abstract] [Full Text] [Related]
5. Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease. Reddy M, Singh S, Rawat A, Sharma A, Suri D, Rohit MK. Rheumatol Int; 2016 Apr; 36(4):551-9. PubMed ID: 26849890 [Abstract] [Full Text] [Related]
6. Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: a systematic review and meta-analysis. Lin KH, Chang SS, Yu CW, Lin SC, Liu SC, Chao HY, Lee MT, Wu JY, Lee CC. BMJ Open; 2015 Apr 14; 5(4):e006703. PubMed ID: 25872939 [Abstract] [Full Text] [Related]
9. N-terminal pro-brain natriuretic peptide can be an adjunctive diagnostic marker of hyper-acute phase of Kawasaki disease. Kwon H, Lee JH, Jung JY, Kwak YH, Kim DK, Jung JH, Chang I, Kim K. Eur J Pediatr; 2016 Dec 14; 175(12):1997-2003. PubMed ID: 27798729 [Abstract] [Full Text] [Related]
13. N-terminal pro-brain natriuretic peptide and prediction of coronary artery dilatation in hyperacute phase of Kawasaki disease. Jung JY, Ham EM, Kwon H, Kwak YH, Kim DK, Lee JH, Jung JH. Am J Emerg Med; 2019 Mar 14; 37(3):468-471. PubMed ID: 29903669 [Abstract] [Full Text] [Related]
14. [Levels of serum brain natriuretic peptide and the correlation to heart function in children with Kawasaki disease]. Sun YP, Wang WD, Zheng XC, Wang JJ, Ma SC, Xu YJ. Zhongguo Dang Dai Er Ke Za Zhi; 2010 Mar 14; 12(3):169-71. PubMed ID: 20350422 [Abstract] [Full Text] [Related]
18. Value of amino-terminal pro B-natriuretic peptide in diagnosing Kawasaki disease. McNeal-Davidson A, Fournier A, Spigelblatt L, Saint-Cyr C, Mir TS, Nir A, Dallaire F, Cousineau J, Delvin E, Dahdah N. Pediatr Int; 2012 Oct 14; 54(5):627-33. PubMed ID: 22414326 [Abstract] [Full Text] [Related]
19. The role of age-specific N-terminal pro-brain natriuretic peptide cutoff values in predicting intravenous immunoglobulin resistance in Kawasaki disease: a prospective cohort study. Shao S, Luo C, Zhou K, Hua Y, Wu M, Liu L, Liu X, Wang C. Pediatr Rheumatol Online J; 2019 Sep 18; 17(1):65. PubMed ID: 31533770 [Abstract] [Full Text] [Related]
20. Analysis of Risk Factors for Coronary Artery Lesion in Children with Kawasaki Disease. Bai B, Ya JL, Yan C. J Coll Physicians Surg Pak; 2022 Aug 18; 32(8):1037-1041. PubMed ID: 35932129 [Abstract] [Full Text] [Related] Page: [Next] [New Search]